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Background: There is an urgent need for clinically effective and cost-effective methods to manage antisocial and
criminal behaviour in adolescents. Youth conduct disorder is increasingly prevalent in the UK and is associated with
a range of negative outcomes. Quantitative systematic reviews carried out for the National Institute for Health and
Clinical Excellence have identified multisystemic therapy, an intensive, multimodal, home-based, family intervention
for youth with serious antisocial behaviour, as one of the most promising interventions for reducing antisocial or
offending behaviour and improving individual and family functioning. Previous international trials of multisystemic
therapy have yielded mixed outcomes, and it is questionable to what extent positive US findings can be
generalised to a wider UK mental health and juvenile justice context. This paper describes the protocol for the
Systemic Therapy for At Risk Teens (START) trial, a multicentre UK-wide randomised controlled trial of multisystemic
therapy in antisocial adolescents at high risk of out-of-home placement.
Methods/Design: The trial is being conducted at 10 sites across the UK. Seven hundred participants and their
families will be recruited and randomised on a 1:1 basis to multisystemic therapy or management as usual.
Treatments are offered over a period of 3 to 5 months, with follow-up to 18 months post-randomisation. The
primary outcome is out-of-home placement at 18 months. Secondary outcomes include offending rates, total
service and criminal justice sector costs, and participant well-being and educational outcomes. Data will be
gathered from police computer records, the National Pupil Database, and interview and self-report measures
administered to adolescents, parents and teachers. Outcomes will be analysed on an intention-to-treat basis, using
a logistic regression with random effects for the primary outcome and Cox regressions and linear mixed-effects
models for secondary outcomes depending on whether the outcome is time-to-event or continuous.
Discussion: The START trial is a pragmatic national trial of sufficient size to evaluate multisystemic therapy, to
inform policymakers, service commissioners, professionals, service users and their families about its potential in the
UK. It will also provide data on the clinical and cost-effectiveness of usual services provided to youth with serious
antisocial behaviour problems.
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This paper describes the protocol for the Systemic Ther-
apy for At Risk Teens (START) trial, a UK evaluation of
multisystemic therapy (MST) [1], an intensive family-
and home-based intervention for young people with
serious antisocial behaviour.
The trial is being conducted at 10 clinical sites across
the UK staffed by a team of therapists who have been
trained in MST. All sites agreed to participate in a rigor-
ous randomised controlled trial (RCT) as a condition of
having a clinical team funded by the UK Department of
Health in their locality. Before the launch of the trial,
each of the 10 sites providing MST will have been oper-
ational in their locality for at least 12 months. This
bedding-in period is intended to give each of the sites
time to set up local steering groups and raise awareness
of their service among referrers (youth offending, social
care, child and adolescent mental health, and education
services), as well as ensuring that the therapists are ad-
hering to the therapeutic model of MST (see below).
Each of the sites will join the trial in phases once all of
these conditions are met to a satisfactory level, and the
research team will then begin its evaluation. The
duration of the evaluation is being funded by the
Department of Health, Department for Education and
Youth Justice Board.
The need for an accessible, effective technology to
manage antisocial adolescents is widely recognised as ur-
gent [2,3]. Youth antisocial behaviour is a common and
serious problem with costly consequences for the young
people themselves, their families and society in general. In
England and Wales, the most recent survey of offending,
crime and justice commissioned by the Home Office
showed that just over one-fifth of all 10- to 25-year-olds
had offended in the past 2 years, and half of these individ-
uals had committed a serious offence, including assault
with injury, vehicle theft and burglary [4]. Among younger
children, aggressive and disruptive behaviour patterns are
associated with peer rejection and school drop-out [5],
and longitudinal research has shown that persistent anti-
social behaviour in youth significantly increases the risk of
criminality, unstable relationships and mental health
problems in adulthood [6]. The economic impact of anti-
social behaviour is also considerable. Individuals displaying
persistent antisocial behaviour at 10 years of age are
estimated to cost society 10 times as much as their non-
delinquent peers by the time they are 28 years old [7].
The most serious youth antisocial behaviour is commit-
ted by a very small group of persistent offenders [8,9].
There is a continuity of disturbance from adolescence to
adulthood [10], and those from low socioeconomic status
families are most likely to remain antisocial in adulthood.
Other negative outcomes include school drop-outs,
substance use, unwanted pregnancy, unemployment,convictions, injuries and illnesses, and a two-fold increase
in mortality [11-13]. The most antisocial 5% of 7-year-old
children are five to ten times more likely to display indices
of serious life failure at age 25, for example, drug depend-
ency, criminality, unwanted teenage pregnancy, leaving
school with no qualifications, unemployment and so
on [14].
In the diagnostic systems developed for classifying men-
tal health disorders of children and adolescents, serious
and persistent antisocial behaviour is primarily associated
with the diagnosis of conduct disorder (CD). CD is the
most common mental health disorder in childhood and
adolescence globally, with a lifetime prevalence of approxi-
mately 10% [2]. It is the most common reason for referral
to child and adolescent mental health services (CAMHS)
in Western countries [15,16]. Its prevalence is increasing
in the UK [17]. Of juveniles with diagnosable CD, more
than three-fifths have severe problems: 29% have pervasive
CD with an average of eight symptoms including aggres-
sion; a further 29% have on average six symptoms, includ-
ing theft and other property-oriented offences but not
violence; and 3% appear to be primarily aggressive [16].
There is also a pessimistic trajectory from CD in youth to
antisocial personality disorder in adulthood [18-21], with
young people with the most severe symptoms most likely
to progress to antisocial personality disorder [22].
CD and its sequelae place a massive burden on indi-
viduals and society, involving not just healthcare services
and social care agencies but the family, neighbourhood,
schools, police and criminal justice system. Welsh and
colleagues [9] estimated the social burden in financial
terms of criminal activity of a cohort of 503 typical boys
(aged 7 to 17 years), comprising the youngest sample of
the Pittsburgh Youth Study of 850 youths in an urban
area. Conservatively estimated over 10 years, the cohort
caused a substantial burden to society in the form of vic-
timisation costs, ranging from a low of $89 million to a
high of $110 million. The group with the most persistent
problems, representing 10.2% (n = 34) of the offending
sample, accounted for half (50.1%) of all self-reported
offences, with eight times the average victim costs
per offender compared with non-persistent offenders
($793,000 to $861,000 versus $101,000 to $147,000).
The cumulative cost to services of individuals diagnosed
with CD in their teens over a period of about 18 years was
estimated, in 1998 values, to be £70,000 [7]. The cumula-
tive costs attributed to individuals with CD can be about
10 times the costs associated with individuals with other
mental health problems [23].
Multisystemic therapy as an intervention for antisocial
behaviour
MST is an intensive family- and home-based intervention
for young people with serious antisocial behaviour [1],
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showing serious and persistent antisocial behaviour
[24]. It aims to prevent reoffending and out-of-home
placements. MST was developed in response to research
on the multidetermined nature of serious antisocial be-
haviour [25], and adopts a social-ecological approach to
intervention [26]. The underlying premise of the social-
ecological approach embedded in MST is that serious
and persistent antisocial behaviour is multicausal; there-
fore, effective interventions address the multiple sources
of offending behaviour that are found not only in the
young person (for example, values and attitudes, social
skills and biological factors) but also in his or her social
ecology (that is, the family, school, peer group and neigh-
bourhood). The key risk factors associated with persistent
and serious antisocial behaviour have been identified
through decades of longitudinal research and include im-
pulsivity and overactivity on the part of the young person;
low levels of parental involvement and harsh, critical par-
enting; high levels of family conflict and disruption; and
the young person’s associations with other deviant peers
(for examples, see [27,28]; for a meta-analytic review see
[29]). Consequently, in MST, the therapist works primarily
with the caregiver to improve his or her parenting skills,
enhance family relationships, increase support from social
networks, encourage school attendance and achievement
for the young person, and reduce the young person’s asso-
ciation with delinquent peers.
MST aims to impact on the entire milieu in which the
young person operates, by using multiple interventions, in
combinations indicated by the clinical picture. The treat-
ment approach integrates theoretical concepts and tech-
niques from systemic and structural family therapy, parent
training, marital therapy, supportive therapy related to
interpersonal problems, social skills components, social
perspective training, behavioural methods (for example,
contingency contracting) and cognitive therapy techniques
(for example, self-instructional training). The therapist has
an active role as case manager (with typical caseloads of
between four and six families), which includes acting as an
advocate to outside agencies. MST has been widely
adopted in the US and in other countries including
Canada, the Netherlands, Norway, Sweden, Denmark,
New Zealand and, most recently, the UK.
Recent, high-quality quantitative systematic reviews
conducted for two separate National Institute for Health
and Clinical Excellence (NICE) guidelines [2,30] have
identified MSTas potentially the most promising interven-
tion for reducing adolescent antisocial and offending be-
haviour and improving individual and family pathology
(albeit with some heterogeneity in the observed out-
comes). There have been 20 randomised trials of MST
[31-37], and although the therapy works exceptionally well
sometimes [32-36,38], it does not do so consistently[39-42]. In the meta-analytic reviews [2,30], the post-
treatment standardised mean difference (SMD) reduction
in offending behaviour was −0.47 (95% CI −0.74, -0.21;
P <0.0001) across seven studies [34-36,43-46]. In eight
studies, parent-rated antisocial behaviour was somewhat
less consistently reduced with MST compared with treat-
ment as usual (TAU; SMD = −0.25; 95% CI −0.52, 0.02;
P = 0.07) [33-35,39,43,44,46,47]. On follow-up ranging
from 12 to 17 months, based on five studies, the SMD
for researcher- or clinician-rated antisocial or offending
behaviour was −0.41 (95% CI −0.93, 0.10; P = 0.10)
[33,36,42,44,48]. Although on continuous outcomes the
follow-up yielded an insignificant effect size, on dichotom-
ous outcomes across six studies the reduction of risk was
significant (risk ratio = 0.72; 95% CI 0.51, 1.0; P = 0.05)
[33,42-44,48,49].
The replicability of the findings from the US in other
countries has been mixed. In large trials in Canada [42]
and Sweden [39], MST failed to reduce antisocial behav-
iour more than the usual services. Although treatment
fidelity may have been lower in these studies than in
earlier studies of MST, fidelity scores did not predict
outcome, at least in the Swedish study [39].
In the first RCT of MST to be conducted in the US
without the direct involvement of the treatment devel-
opers, reoffending rates in the MST group remained
high even though the intervention significantly reduced
reoffending compared with TAU (66.7% versus 86.7%)
[49]. Effect sizes associated with efficacy are substantially
higher in trials of MST that involved the developers
(0.81) than in studies conducted without their close in-
volvement (0.27) [31]. This pattern of results leaves open
the possibilities of ‘developer effects’ and that the rela-
tive success of MST may be due to the poor quality of
the standard services for managing CD in the US. Thus,
for MST to be considered valuable, its superiority should
be demonstrated outside the US in care systems meeting
the following three conditions: the evidence base for
TAU (associated with socialised healthcare systems) is
stronger than for TAU in earlier clinical trials initiated
by the developers of MST (for example, individual psy-
chotherapy); the motivation of the therapists delivering
MST to demonstrate favourable outcomes associated with
the therapy is lower than that of those who were involved
in the development of MST; and sentencing policy within
the justice system does not result in a comparison with al-
ternatives, such as custodial sentences.
These three conditions were met with the first UK RCT
of MST conducted at the Brandon Centre in London,
which evaluated whether MST (n = 56) or the comprehen-
sive, targeted services delivered by youth offending teams
(YOTs; n = 52) was more effective in reducing offending
and out-of-home placement in an ethnically diverse, urban
sample of young people [44]. MST was provided by a
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with the development of MST and evaluated by similarly
independent researchers. The results of this trial showed
that, although young people receiving either MST or YOT
interventions showed improvement in terms of reduced
offending, the MST model reduced the likelihood of non-
violent offending during an 18-month follow-up period sig-
nificantly further. Consistent with the data on offences, the
results of youth-reported delinquency and parental reports
of aggressive and delinquent behaviours showed signifi-
cantly greater reductions from pre- to post-treatment levels
in the MST group. In this study, MST was observed to have
a delayed impact on offending, with between-group differ-
ences emerging only at 18-month follow-up. The authors
concluded that the superiority of MST over YOT services
in reducing offending and antisocial behaviour suggests that
MST adds value to current UK statutory evidence-based
youth services. It was suggested that the provision of MST
would not supplant existing services but would be best
used to facilitate appropriate and cost-effective organisation
of statutory services for young people and their families.
Although the Brandon Centre trial was a good first
step in assessing the appropriateness of MST as a robust
intervention for addressing serious antisocial behaviour
in the UK, it had several important limitations. First, the
sample size was relatively small, and the study was also
underpowered to investigate the mechanisms of change
believed to be responsible for the success of MST, such
as improved parent-youth relationships and decreased
affiliations with delinquent peers. Second, the secondary
measures used to study mediators and moderators of
treatment change were administrated at only two time
points - before and after the intervention - and not at
the 6-, 12- and 18-month follow-up periods where ob-
jective offending data were collected. As a consequence,
the nature of, and causes responsible for, the delayed im-
pact of MST on offending could not be ascertained. Fi-
nally, the trial examined the effectiveness of MST in
youth offenders from a localised population (two bor-
oughs in London) rather than the larger population of
antisocial youth that are seen across child and youth ser-
vices (YOTs, social care, CAMHS) across the UK. The
target population and ecological context of the trial is
important to consider, as provision of MST in the UK
has expanded from one team at the Brandon Centre
when the RCT was initiated in 2003 to over 30 teams
currently functioning across the country. This expansion
is a direct result of a UK government policy decision to
help troubled families whose children and young people
exhibit truanting and antisocial behaviour.
The current trial
There are several unresolved issues relating to trans-
porting MST to other health and social care systemsand jurisdictions, in addition to the obvious issue that
the proposed application (in the context of the current
trial) is broader than the targeted samples of previous
trials (see below). Additionally, in relation to a UK trial
at least, the following issues require systematic monitor-
ing: the clinical competences of therapists to practise
MST in the light of curriculum differences for psycholo-
gists and social workers in the UK and the US; the
stronger evidence base of usual services in the UK than
TAUs used in previous clinical trials initiated by the de-
velopers of MST; differences in the motivation of MST
therapists and the research team who were not involved
in its development; contextual issues such as differences
in national standards with regard to sentencing policy
and practice; the need for appropriate measures and
sufficient data for examining mediators (mechanisms
accounting for the effects of treatment) and moderators
(conditions that qualify the usefulness of treatment) be-
fore, during and at the end of treatment; and the need
for person-centred statistical analyses to identify typical
trajectories of response (for example, for individuals
with or without callous-unemotional (CU) traits). It is
therefore essential for this major UK trial to include as
much detail as possible about the types of YOT and
other services made available to young people in the
comparator arm, including frequency of contacts with
professionals.
START is a national RCT to evaluate MST in the UK
context. It has been designed as a pragmatic trial that will
inform policymakers, commissioners of services and pro-
fessionals about the potential of MST in the UK context.
Aims
The primary aim of START is to establish whether MST
is more effective than management as usual (MAU) in
reducing out-of-home placement in a sample of adoles-
cents at high risk of being removed from their homes
because of antisocial behaviour. Secondly, the trial aims
to determine whether the provision of MST leads to im-
proved well-being for young people and their families,
including improved emotional and behavioural function-
ing for the young person, closer family relationships, im-
proved parenting skills, improved educational outcomes
and reduced offending behaviour. Thirdly, the trial will
establish whether MST is cost-effective compared to
MAU and results in reduced costs across mental and
physical health, criminal justice and educational systems.
Finally, in terms of secondary outcomes, the trial will
examine the mediators and moderators of treatment
change, and determine whether specific groups of young
people presenting with antisocial behaviour benefit to a
greater or lesser extent from the intervention. Consistent
with extant mediational studies of MST trials with a
range of juvenile offenders [48,50], we will test whether
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group of antisocial adolescents in the UK; namely, that
MST treatment processes will result in improvement on
key family and peer risk factors associated with anti-
social behaviour, and that improvements in these risk
factors will result in decreased adolescent antisocial
behaviour.
In addition, we will improve on previous MST trials,
which have rarely examined empirically derived modera-
tors of antisocial behaviour, by studying whether treat-
ment outcome is influenced by the onset of participants’
antisocial behaviour, as well as their level of attention
deficit hyperactivity disorder (ADHD) symptomatology
and CU traits measured at the beginning of the inter-
vention. Early-onset antisocial behaviour, comorbid diag-
noses of ADHD and CD, and high levels of CU traits
have been associated with greater severity of antisocial
behaviour and poorer youth justice outcomes. For ex-
ample, early-onset antisocial behaviour has been shown
to be the best predictor of early arrest (before the age of
13) and, in turn, young people with an early arrest are
the most likely to be chronic offenders by the age of 18
[51,52]. Clinical studies of children with ADHD show
that they are at high risk for delinquency [53], and chil-
dren with comorbid diagnoses of ADHD display more
early-onset and severe forms of antisocial behaviour
[54]. Research over the past 15 years has demonstrated
that antisocial adolescents with high CU traits are more
likely to develop severe and violent delinquency over
time [55,56], and show more severe and aggressive be-
haviour [55,57-59]. We propose that young people in the
trial showing early-onset antisocial behaviour and high
levels of ADHD symptoms or CU traits may benefit less
from MST than young people who do not show these
characteristics or vulnerabilities.
Methods/Design
Trial design
The START trial is a multicentre pragmatic clinical RCT
comparing MST with carefully documented MAU for
adolescents meeting criteria for being at high risk of re-
quiring out-of-home placement, specifically when this
risk is associated with antisocial behaviour, including
conviction as a young offender. Whereas previous US
trials of MST for youth antisocial behaviour have exclu-
sively recruited offenders from the juvenile justice sys-
tem, and European trials in Norway [45,60] and Sweden
[39] have studied young people served by the child wel-
fare system who have not committed crimes, the current
trial will be unique in recruiting a broader range of anti-
social young people seen by the range of services and in-
stitutions designed to manage antisocial behaviour in the
UK. These include YOTs, CAMHS, social services and
social care, and the educational system. Consequently,although the common referral criterion is antisocial be-
haviour, young people will be recruited from various set-
tings where their antisocial behaviour is manifest in
different ways (see Inclusion criteria below).
Ethics
The study protocol was approved by the London-South
East Research Ethics Committee (reference number 09/
H1102/55). Research and development approval has also
been sought and given for each trial site by the relevant
NHS Trust in each geographical area.
Study setting
The study involves each of the 10 MST pilot sites in the
UK. Recruitment at each site will take place for 18
months, commencing about 12 months after the inaugur-
ation of the programme at each site (sites have begun the
programme at different time points), to ensure the embed-
ding of MST at each site before randomisation begins,
as described above. At each site, a team of four MST ther-
apists is guided by a supervisor - a doctoral-level (or mas-
ter’s-level with significant clinical and supervisory
experience) therapist with sound knowledge of the theor-
ies underpinning MST and their application, and experi-
ence in providing clinical supervision. The MST supervisor
conducts weekly group supervision, and one-to-one super-
vision if needed, of the MST therapists at a site to ensure
they are adhering to MST principles in their practice. The
supervisor is also involved in the selection of young people
referred to the service as suitable for MST (see Recruitment
and baseline procedures below).
Participants
Overall, 700 participants are being recruited, with ap-
proximately half of the consecutive qualifying cases be-
ing randomised to MST alone, and the other half to
MAU. The unit of randomisation is the individual
participant.Sample size and power calculation
It is estimated that each site will have at least 140 fam-
ilies per year referred for treatment. On the basis of
past experience, data from a meta-analysis of previous
trials of MST (including major effectiveness trials from
the US) that was carried out in the course of prepar-
ation of the NICE guidelines [2], and assumptions
outlined below, the investigators assume that about
30% of referred families will meet the criteria and agree
to randomisation; this implies that each site will be able
to recruit and treat 70 to 80 families during a recruit-
ment window of 18 months. Therefore, investigators
expect to be able to recruit and assess 700 participants
(350 in each arm). Figure 1 shows the expected flow of
Youth offending teams 
(young offenders)
Children’s services
(at risk of out-
of-home placement)
CAMHS 
(chronic severe
conduct problems)
Educational services
(permanent school
exclusion)
Multi-agency panel
(screen 1)
N=2117
Randomisation by 
clinical trials unit
N=700
Letter offering visit by MST staff
N=1764 
Explanatory visit by MST team 
(screen 2)
N=1470
Consenting and baseline 
assessment (screen 3)
N=784
Phone appointment offered
for research assessment
N=1176
MST
N=350
MST
N=333
MST
N=300
MST
N=316
Inappropriate referrals
for MST
Fail to return reply slip
Not eligible – fail
to meet criteria
Refuse to proceed to
baseline assessment and
randomisation
Not eligible
Fail to meet 
criteria
Consent 
to data 
collection
MST
N=350
MAU
N=350
MAU
N=333
MAU
N=300
MAU
N=316
MAU
N=350
6 months post-randomisation
First measures of secondary outcome
12 months post-randomisation
Follow-up measures of secondary outcome
18 months post -randomisation
Follow-up measures of secondary outcome
Available for intent -to-treat analysis of primary 
outcome
Endpoint for primary outcome
20 %
20 %
25%
33 %
12 %
80 %
80 %
75 %
67 %
88 %
Referrals from:
50 %50 %
Figure 1 CONSORT flow diagram of progress through the phases of recruitment and treatment in the START trial of multisystemic
therapy. CAMHS, child and adolescent mental health services; MAU, management as usual; MST, multisystemic therapy.
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the study.
Assuming that 30% of the MAU arm will have
out-of-home placements, this sample size will give 86%power to detect a 10% difference in out-of-home place-
ments (a reduction from 30% to 20%). To take account
of within-therapist correlation of outcomes in the MST
arm, an intraclass correlation of 0.02 and a total of 30
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1.22 in the MST arm and 1.0 in the MAU arm, and
thus reducing the power to 83%.Eligibility criteria
Inclusion criteria
The study design aims to increase generalisability of the
findings beyond the group of adolescents under study by
using the minimum number of entry criteria. The task
of establishing an adolescent target population based on
the status of ‘being on the edge of care’ is challenging
as, in most contexts, this term covers a heterogeneous
group. At the same time, it was recognised that the four
referral routes used in the study (YOTs, social care,
CAMHS or education services) often identify young
people and families with very similar needs when they
have reached a particular crisis point. The nature of the
crisis may be associated with the specific service (for ex-
ample, YOTs are triggered by convictions, education ser-
vices by repeated school exclusions) but the underlying
causes in terms of family disorganisation, conflict and
stressors, combined with antisocial behaviour by the
young person, are similar, and the outcomes in terms of
risk of out-of-home placement are common to them.
All participants, regardless of referral source, must
meet the following general inclusion criteria:
 Young person aged 11 to 17 years;
 Sufficient family involvement for MST to be applied;
 No existing agency involvement that would interfere
with MST (for example, the family is already
engaged with a therapist);
 Displaying antisocial behaviour manifesting as at
least one of the following criteria indicating
suitability for MST:o Persistent (weekly) and enduring
(6 months or longer) violent and
aggressive interpersonal behaviour;
o A significant risk of harm to self or to others
(for example, self-harming, substance misuse,
sexual exploitation, absconding);
o At least one conviction and three warnings,
reprimands or convictions in the past 18 months;
o Current diagnosis of an externalising
disorder and a record of unsuccessful
outpatient treatment;
o Permanent school exclusion.
In addition, participants must meet at least three of
the following criteria, which are indicative of risk status
and serve as generic indicators of risk sufficient to war-
rant referral to services: Excluded from school or at significant risk of
exclusion;
 High levels of non-attendance at school;
 A history of offending, or at significant risk of
offending;
 Previous episodes on the Child Protection Register;
 Previous episodes of being ‘looked after’, that is,
placed outside of the home (whether via
incarceration, psychiatric hospitalisation, residential
schooling or assignment to residential local
authority care);
 Previous referral to a Family Group Conference
(usually a meeting between the family members and
sometimes also friends or neighbours, the young
person and his/her supporter or advocate if
requested, and professionals from the health,
education or social services to discuss, plan and
make decisions regarding a child at risk to prevent
the young person from becoming looked after)
 History of siblings being looked after and taken into
local authority care.
Guidelines were developed for inclusion depending on
the nature of the referral. The specific inclusion criteria
for the four agencies and referral paths are briefly sum-
marised in Table 1.
Exclusion criteria
The exclusion criteria applied were:
 History or current diagnosis of psychosis;
 Generalised learning problems (clinical diagnosis) as
indicated by intelligence quotient (IQ) below 65;
 Identified serious risk of injury or harm to a
therapist or researcher;
 Presenting issues for which MST has not been
empirically validated, in particular, substance abuse
in the absence of criminal conduct or sex offending
as the sole presenting issue.
Recruitment and baseline procedures
The recruitment process is fundamental to the success
of this large, multisite research trial. In addition to cri-
teria that apply to recruitment for any trial (for example,
the clear application of eligibility criteria, a standard pro-
cedure for obtaining informed consent), recruitment for
this trial must be especially sensitive to the community
context and be based on effective partnerships with re-
ferral agencies and strong relationships with the young
people and their families. Consequently, the trial team
has developed strong collaborative relationships with the
MST team at each site to achieve the high levels of ac-
crual necessary to ensure sample comparability and rea-
sonable generalisability.
Table 1 Inclusion criteria by referral source in the START trial of multisystemic therapy
Referral source Inclusion criteria specific to the sourcea
Children’s services • Designated as ‘child in need’ where this is associated with antisocial behaviour on the part of the adolescent
• Exhibiting extremely challenging behaviour by either persistent (weekly) and enduring (6 months or longer)
violent and aggressive interpersonal behaviour and/or a significant risk of harm to self or to others
(for example, self-harming, substance misuse, sexual exploitation, absconding)
Youth offending teams • At least one conviction within the past 12 months, or referral via a supervision order with multisystemic
therapy as a specified activity
• A warning, reprimand and/or conviction on at least three occasions in the past 18 months
Child and adolescent mental
health services
• Current diagnosis of conduct disorder, substance misuse, major depression or anxiety
• History of at least one unsuccessful outpatient intervention
• Either history of school exclusion or assessment as ‘child in need’
Educational services • Currently permanently excluded from school
• History of having been excluded from at least one other school for aggressive conduct
aAll participants must also meet the general inclusion criteria described in the text.
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recruitment based partly on the experience of the MST
trial conducted at the Brandon Centre [44]. Using this
procedure, decisions about eligibility for the trial have
been made at three points: by the multi-agency panel;
through discussions between the MST supervisor and
trial coordinator on the basis of information gathered
from the referral form; and through discussions between
the MST supervisor and trial coordinator following gath-
ering of initial information by the clinical and research
teams after an introductory home visit to explain the ra-
tionale for the research trial and answer any questions
about the clinical services potentially available to the
family. Experience suggests that each of these screens
tends to reveal different criteria for ineligibility, and their
use in combination minimises the (considerable) effort
of recruitment. For example, the multi-agency panel re-
view tends to identify referrals for issues for which MST
has not been empirically validated (for example, sex
offending as the sole presenting issue), whereas discus-
sions between the MST team and family or referral
source most commonly identify a risk of possible injury
to a worker or agency involvement precluding inclusion
in the trial.
Finally, the research assessor’s (RA) assessment is ne-
cessary to confirm the young person’s IQ and psychiatric
diagnosis.
Screen 1
Multi-agency panels have been put in place at each of the
10 sites, taking referrals from YOTs, CAMHS, social care
and education services. These panels identify new cases
that meet the eligibility criteria for MST. In addition, the
MST team at each site directly takes referrals, as they have
become established and connected with other services and
referral sources in each of their localities. The decisions
made by the multi-agency panels and the MST teamconstitute the first screen. During the period between es-
tablishment of the teams and the start of the trial, each
MST team gained experience in screening referrals and
educating potential referrers as to what constitutes an ap-
propriate referral to the trial. A standard referral form for
each locality is used in liaison with the research team, in-
cluding specific information pertaining to inclusion and
exclusion criteria. This forms the first screen to the trial,
focusing on establishing the severity and chronicity of
antisocial behaviour.
Screen 2
Following acceptance of the referral by the multi-agency
panel, a standard initial letter from the clinical team, in
the first language of the family, is sent to the parents
and separately to the young person if aged 16 or over,
informing them about the trial. Recruitment begins with
this letter, which is sent to all those identified by a panel
and/or MST team to be probably suitable for MST. The
letter invites participation, and informs the family and
the young person that someone from the MST team
(preferably the MST supervisor) will contact them unless
they do not wish to participate in the trial. The letter in-
cludes material in age-appropriate and culturally appro-
priate language in the form of a leaflet for both the
parents and the young person explaining the trial and
what involvement in the trial would mean at that particu-
lar site. These information sheets have been constructed
and designed with input from young people and their par-
ents or carers who have used MST at the same site to
make them as useful and accessible as possible.
After 3 to 7 days the family is visited by a member of
the MST team to explain what participation might in-
volve and to arrange an appointment at the family home
that will include the MST supervisor or therapist, the
RA, the young person and his or her primary carer(s).
The discussions at this meeting include the identification
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able alternative treatment at that locality; see below)
should the young person not be randomised to receive
MST.
At this meeting, which constitutes the second stage of
the multiple screening procedure, the MST therapist
identifies possible exclusion criteria, such as a risk of in-
jury or harm to a worker, agency involvement incompat-
ible with participation in the trial, or severe substance
dependency. Consent forms are not signed at this ap-
pointment because experience has shown that actual
take-up of treatment increases dramatically and early
drop-outs are reduced if the family feels they have been
given adequate time to consider participation.
Screen 3 and consent
Unless the family expresses a decision not to participate
at the time of the visit or within 3 to 7 days after the
visit, a telephone contact is made by the RA, offering a
research assessment. At this stage the consent form is
reviewed. Consent forms signed by both the young per-
son and carer(s) include permission to access the police
and correctional databases, remaining in effect for 3
years. For families who sign the consent forms, the RA
administers pre-randomisation questionnaires and mea-
sures are completed during this contact (that is, before
group assignment). The final evaluation for eligibility
(the third screen) is made at this second visit.
When all the instruments have been completed and
eligibility for the trial confirmed, the RA telephones the
trial centre to inform the centre of the family’s random-
isation details. The randomisation is performed and
details communicated to the referrer and family within
24 hours.
Randomisation and procedures to minimise bias
After consent has been obtained and the baseline assess-
ment has been carried out, a trial identification is
assigned. Eligible consenting participants are randomised
to MST or MAU on a 1:1 basis by the Trials Unit at
University College London using a secure telephone ran-
domisation service that ensures allocation concealment.
A computer-generated adaptive minimisation algorithm
that incorporates a random element is used with the fol-
lowing stratification factors: treatment centre, gender,
age (11 to 14, 15 to 17) and age at onset of conduct
problems (2 to 11, 11+). These strata were selected be-
cause previous research has shown that a younger age of
onset is associated with poorer prognosis; there is insuf-
ficient evidence concerning gender mix, particularly in
the older age groups, to ensure that simple randomisa-
tion would generate comparable groups. Treatment
centre is included in the minimisation stratification to
control for differences between centres.To minimise bias that could arise from knowledge of
treatment allocation, the following strategies are
employed: RAs are blind to treatment allocation; the RA
and therapist do not communicate directly (if at all) with
each other; qualitative interviews, conducted with a sub-
sample of the families by doctoral students trained and
supervised by experienced qualitative researchers, are
audiotaped and a random sample re-rated by independ-
ent raters. The qualitative interviewers are separate from
the MST service providers.
Planned interventions
Multisystemic therapy
There are a number of factors that contribute to the
unique nature of MST: it addresses the multidetermined
nature of severe conduct problems; it sees the caregiver
as key to effective behaviour change; it uses the adoles-
cent’s home as the primary site of the intervention; it in-
tegrates several evidence-based intervention techniques;
it uses a single therapist to deliver multiple modalities of
intervention within a singular conceptual framework;
and there is rigorous monitoring of adherence to the
model, including the use of comprehensive quality assur-
ance and on-going quality improvement system for
maintaining standards.
MST is a family- and community-based intervention
that uses intense contact with a family to understand and
address the drivers of a young person’s antisocial behav-
iour. It targets drivers related to the young person’s indi-
vidual adjustment, family relationships, school functioning
and peer group affiliations. A focus on the caregiver and
family is key to the intervention. MST interventions are
individualised and highly flexible but are documented in
treatment manuals [61]. The package is designed to work
with hard-to-reach families in the community and pro-
vides a duty cover system 24 hours a day, 7 days a week to
ensure that families receive support from the MST team
at the times when crises are occurring. Although the pack-
age comprises a number of evidence-based interventions,
it is designed to be delivered by one highly trained profes-
sional, typically a mental health professional with graduate
training in one of a variety of disciplines (for example,
clinical psychology, social work) with a caseload of four to
six families. The MST therapist is a full-time generalist
who directly provides most of the mental health interven-
tions and directs access to services, coordinating these to
monitor quality control. The therapist is available to the
family 24 hours a day, 7 days a week but input is adjusted
according to need. Treatment fidelity is ensured by weekly
group supervision meetings between therapists and the
MST supervisor; these meetings may also include a med-
ical consultant. Treatment generally lasts 3 to 5 months.
Sessions are held in the family’s home and in community
locations [61]. Especially in the beginning, the therapist
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the young person’s parent or principal carer on days when
no visit has been arranged. The MST therapist also spends
time at the young person’s school as needed and meets
with the young person’s peer group and extended family.
A key early part of the process is to engage the family, a
significant challenge in some cases.
Despite incorporating a range of modalities, MST is
more than just an amalgamation of techniques and ap-
proaches, and a focus on the inter-relationship between
social, education and healthcare systems is retained. The
overarching goals of MST are to give parents the skills
and resources needed to address the inevitable difficul-
ties of raising adolescents, and to empower adolescents
to cope with familial and extrafamilial problems. Assess-
ment and treatment explore the adolescent’s role in vari-
ous systems and consider the inter-relationship between
these systems. Specific attention is given to strengthen-
ing the various systems, and an attempt is made to pro-
mote appropriate and responsible behaviour among all
family members. MST focuses on current behaviours as
opposed to influences from the young person’s past. It
seeks to identify, reduce and, if possible, remove behav-
iours that are of concern to the referring service and the
young person’s parent or principal carer. The implemen-
tation of MST draws on family members, in contrast to
many interventions that define the young person as the
‘identified client’. In addition, collaboration with com-
munity agencies is a crucial part of MST. For instance,
establishing (or in most cases re-establishing) engage-
ment between the young person, the parent(s) and the
school is a critical part of the treatment, and the MST
therapist may be in regular contact with teachers. The
MST therapist also works in close partnership with the
social worker from the YOT or social services, who may
have statutory responsibilities for the young person.
When considered necessary, the young person is re-
ferred to a general practitioner or other medical profes-
sional who can assess the young person and prescribe
medication.
As mentioned above, the MST teams are centrally
funded by the Department of Health and had already
been operational for approximately 12 to 18 months
prior to their participation in the START trial. These
factors benefit the RCT in several respects. First, at the
start of the trial the clinical teams had already developed
relationships with key stakeholders and referrers in their
local communities, and multi-agency panels had been in
operation to facilitate recruitment. Second, the clinical
teams had already had the opportunity to liaise with po-
tential sources of referrals regarding the appropriateness
of referrals, and thus to ensure that referral of inappro-
priate cases is minimised. Third, as the funding of the
MST teams is tied to participation in the research trial,the collaboration between the MST clinical teams and
the research team to achieve common goals (for ex-
ample, recruitment numbers, implementation of ran-
domisation, completion of the research protocol) is
maximised. Finally, by the start of the trial, the therapists
and supervisors would have been able to develop experi-
ence implementing MST; research suggests that mature
MST teams are associated with greater adherence of thera-
pists to the MST model. The association between treat-
ment fidelity and outcomes for adolescents has been
repeatedly demonstrated in trials of MST [35,39,48,50]. To
mitigate the dissipating influence of poor adherence, the
MST developers have developed an extensive quality assur-
ance system [62]. In common with all MST sites, the 10
START trial sites were licensed by MST Services Inc.
(Charleston, SC, USA), and therefore participated in MST
Services’ quality assurance procedures. As well as the
weekly supervisions with the MST supervisor, the thera-
pists receive a one-hour weekly telephone consultation
with an MST expert, on-site booster training sessions four
times per year, and twice-yearly implementation reviews by
the MST expert. The supervisor guides clinical work
according to the MST Supervisory Manual, and in deliver-
ing MST the trial team adheres to the MST Organizational
Manual [63].
Management as usual
MAU consists of the standard care offered to adoles-
cents and their families who meet eligibility criteria for
the trial in each of the sites. This treatment is likely to
be diverse and may involve no therapeutic intervention
or individual- or family-oriented work. It is likely to be
delivered by a wide range of practitioners with different
theoretical orientations. The average duration of these
interventions is also likely to vary. It is expected that
practitioners will be working in line with best practice as
specified in relevant Social Care Institute for Excellence
and NICE guidance [2,30].
Based on assessments, the young people in the MAU
group receive a tailored range of interventions aimed
primarily at preventing reoffending. As in MST, typical
interventions are extensive and multicomponent, con-
sistent with the complex mental health needs of this
population in the UK [64]. Interventions include helping
the young person to re-engage in education; help with
substance misuse problems and anger management; so-
cial problem-solving skills training; and awareness pro-
grams relating to vehicle crime, violent offending and
knife crime. It is likely that victim awareness and repar-
ation interventions will be included as appropriate. The
treatments are delivered by professional social workers,
specialist therapists or probation officers.
The key differences between MST and MAU are that
MAU interventions are not normally delivered in a
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arching model governs the selection of treatments, and
there is no set of principles comparable to that of MST
to organise the therapies offered. Rather, interventions
are likely to be offered on an ‘as needed’ basis by special-
ist agencies to which the young person is referred. The
young people allocated to MAU are likely to receive
considerable attention from a range of professionals de-
livering evidence-based protocols. In a recent RCT com-
paring MST with usual services provided by YOT,
clients typically received around 21 professional appoint-
ments over the period that MST was administered
[44,65]. It is unlikely that practitioners in MAU receive
the extent or quality of supervision available for MST
therapists. However, it is by no means clear that, even dur-
ing the trial period, MAU interventions are likely to be less
intensive or less costly than MST, although they are likely
to be delivered in a less focused and less well-specified
manner, with greater variability in service provision. In the
Brandon Centre trial [44], young people in the control arm
attended significantly more appointments than those in the
MST arm. This was in line with the National Standards set
out by the UK Youth Justice Board for the key contact and
enforcement community [66].
For this reason, MAU interventions in the current trial
are carefully monitored using a service use schedule
designed specifically for the trial, which records contact
with all services (health, social, YOT, education, volun-
tary sector, and so on), including the number of contacts
(and possibly the average duration of contacts). This will
give a realistic sense of the level of intensity of MAU in
whatever form, and, used in conjunction with the MST
arm, will give an indication of shifts in intensity - that is,
whether the addition of MST reduces the need for other
support. As START is a pragmatic trial involving a num-
ber of collaborating services even within each individual
site, it was not possible to specify in advance what MAU
would constitute.
Assessments and outcome measures
To maximise the clinical validity of the outcome evalua-
tions, assessments are being made across multiple do-
mains using multiple methods and sources.
Primary outcome
The primary outcome is the proportion of cases assigned
to long-term (3 months or longer) out-of-home place-
ments in specialist residential provision, including place-
ment into local authority care, incarceration, long-term
hospitalisation and residential schooling, at 18 months
following randomisation. The investigators expect this
trial to give information on how many children assigned
to MAU and MST require specialist residential provision
either immediately or during the follow-up period.Secondary outcomes
The number of secondary outcomes is limited to re-
duce the measurement burden of the study, which was
found to be a disincentive to continued participation in
the Brandon Centre study [44]. The domains that the
investigators consider key to the intervention are youth
offending outcomes, adolescent well-being outcomes
and family functioning outcomes. In addition, the eco-
nomic data collected alongside these outcomes are con-
sidered highly important. The study is also designed to
collect data on variables that target key mechanisms of
change identified in previous MST studies - parent-
adolescent relationships and young people’s associa-
tions with deviant peers - and to evaluate parenting
skills in detail, given that MST aims to improve young
people’s lives by targeting caregivers as being primarily
responsible for facilitating change. Adolescent symp-
toms have been shown to decrease in association with
increased supportiveness and decreased conflict be-
tween parents [67,68] and with an increased caregiver
follow-through on discipline practices [69]. Further, ad-
herence to the MST manual by therapists appears to
improve family functioning, which in turn decreases
deviant peer affiliation, leading in turn to decreased de-
linquent behaviour [50].
Objective measures
Objective secondary outcomes will be collected from re-
ports of offending behaviour based on police computer
records, including details of custodial sentences. These
measures will be taken at 6-monthly intervals, for the 6
months before randomisation, the 6 months covering
the intervention period, and 6-monthly until the 18-
month follow-up point. The number of records of
offending behaviour (count data) will be obtained and
6-month periods free of any offending behaviour will
also be recorded (binary data). Records are obtained
from the Police National Computer as well as from the
Young Offender Information System database at each
site; these records detail information on offences, court
appearances, criminal orders, police custody records
and arrest rates.
Records of school attendance and exclusions will be
retrieved from both the local schools themselves and the
National Pupil Database to assess educational outcomes.
Self-report
The RA administers pre-testing questionnaires during
the initial contact with the young person and family after
they have given consent to participate in the trial, prior
to group assignment (as described above). Post-testing
by the RA is scheduled for 6 months after entry into the
study; it is envisaged that this will be a minimum of 2
weeks after the family completes the intervention.
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months post-randomisation.
Self-report measures of well-being and adjustment,
antisocial behaviour, parenting skills and family func-
tioning as well as parental mental health and adjustment
are collected.
Well-being and adjustment. A general assessment of
well-being is taken using the Strengths and Difficulties
Questionnaire [70]. Educational outcomes will include
evaluation of participants’ emotional and behavioural
functioning in the classroom using the Conners Com-
prehensive Behaviour Rating Scale-Teacher report form
[71]. Depression will be monitored using the Short
Mood and Feelings self-report questionnaire [72], com-
pleted by the youths.
Antisocial behaviour. The prevalence and incidence of
delinquent behaviour such as vandalism, theft and burg-
lary will be monitored using the Self-Report Delinquency
measure [73]. Noncompliance and increasingly serious
forms of antisocial behaviour, together with young peo-
ple’s perceptions of law-abiding behaviour and institu-
tions, will be measured using the Antisocial Beliefs and
Attitudes Scale [74]. Peer delinquency will be assessed
using the Self-Report Delinquency measure [73]. The in-
vestigators predict that MST will achieve decreases in
associations with other antisocial peers, increases in
positive peer relations and greater commitment to pro-
social activities (for example, education). This prediction
is consistent with the model and hypothesised mediating
mechanisms [50] and is relevant to social policy initia-
tives and concerns.
Parenting skills and family functioning. The quality of
the parent-adolescent relationship, family functioning
and parenting practices will be evaluated using the
Family Adaptability and Cohesion Scales [75] and the
Alabama Parenting Questionnaire-Short Form [76]. Paren-
tal disruption will be assessed using the short form of the
Conflict Tactics Scale [77], and the level of expressed emo-
tion in the home (as conceptualised in the Camberwell
Family Interview) will be assessed using the Level of
Expressed Emotion questionnaire [78,79].
Parental mental health and adjustment. A brief as-
sessment of parental mental health will be obtained
using the commonly used screening instrument, the
General Health Questionnaire-28 [80].
Interviews
Demographics interview. A bespoke interview (Demo-
graphic Interview for Parents) to cover general family in-
formation, including parental forensic history, schooling
and economic information, has been constructed and
will be administered to all parents. Child psychometrics
will be obtained from the Wechsler Abbreviated Scale of
Intelligence [81].Psychiatric screening. Psychiatric disorders will be identi-
fied and a psychosis screen provided by the Development
and Well-Being Assessment [82]. This computerised
structured interview measure is administered to both the
parents and young person.
Experience of MST. Finally, young people and their
carer(s) will be interviewed to elicit their views regarding
their experience of MST and factors that they perceive
had facilitated or inhibited therapeutic change, based on
promising qualitative research carried out during the
Brandon Centre trial.
Health economic evaluation
Health economic analysis will be conducted by the
Centre for the Economics of Mental Health at the Insti-
tute of Psychiatry, London, to explore the relative costs
and cost-effectiveness of MST and MAU. The evaluation
will take a broad perspective, including all health, social
services, education and voluntary sector services, plus
costs to the criminal justice sector, costs resulting from
crimes committed, and out-of-pocket expenses to the
young people and their families.
Data on MST contacts will be collected directly from
the pilot schemes to avoid participants revealing their
group allocation to the RAs. Data on the use of all other
services will be collected in interviews using the Child and
Adolescent Service Use Schedule previously used with
young people with complex mental health and social care
needs [83-86]. The Child and Adolescent Service Use
Schedule will be adapted to the current study population
by review of the literature and pilot testing, to ensure
comprehensive coverage and face validity. The cost of the
trial interventions will be calculated through a detailed
micro-costing (or bottom-up) approach using standard
costing methodology [87,88], which will involve estimation
of the indirect time spent on individual cases, including
preparation, meetings, telephone calls and supervision, as
well as detailed recording of direct face-to-face contact.
Moderators of outcomes
Therapist adherence to the multisystemic therapy model
of intervention
The MST Therapist Adherence Measure-Revised (TAM-R)
measures the team’s adherence to the nine MST treatment
principles [50]. The TAM-R is a 28-item measure com-
pleted by parents or primary caretakers, often adminis-
tered by the MST team. In the START trial it will be
administered independently from the MST team by an
RA not associated with that site or the families working
with it. Data will be collected from the second week of
MST treatment and every 4 weeks thereafter. Research
has demonstrated associations between therapist adher-
ence to the MST principles as measured by the TAM-R
and youth outcomes [35,39,48,50,89-91].
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disorder
The trial will also evaluate potential moderators that have
not been widely explored in previous studies because of
sample size constraints, and will consider in particular the
role of psychiatric comorbidities including psychopathic
traits and ADHD. Young people with high levels of psy-
chopathic traits show a greater likelihood of recidivism
[92], and one study found that young children high for
CU traits showed poorer outcomes in a parent training
programme for children [93]. It is well established that the
combination of ADHD and antisocial behaviour is associ-
ated with greater amounts of physical aggression, a greater
range of persistence of antisocial activity [94] and the per-
sistence of antisocial outcomes in adulthood [95]. Psycho-
pathic traits will be assessed using the Inventory of
Callous-Emotional Traits [96], and the Diagnostic and
Statistical Manual of Mental Disorders 4th edition ADHD
subscales from the Conners Comprehensive Behaviour
Rating Scale [71] will be completed by parents and
teachers to assess hyperactivity and impulsivity across
home and school settings. ADHD diagnoses will also be
arrived at categorically using the Development and Well-
Being Assessment (see above).
Programme components of multisystemic therapy and
management as usual
A bespoke fidelity measure has been developed to enable
accurate characterisation of the programme components
of MST and MAU interventions, the Children and
Young People – Resources, Evaluation and Systems
Schedule (CYPRESS) (S. Pilling, S. Butler, C. Gaffney, P.
Fonagy, personal communication). This approach is
based on the initiative of the MST developers [62], who
have undertaken a large-scale transportability study with
2,000 families, 429 therapists, 122 supervisors and 20
consultants. Organisational structure and climate as
rated by the therapists, supervisors and consultants ap-
pears to predict the outcome of MST [97]. CYPRESS
was designed to characterise care pathways for antisocial
youths in a UK context. It will be administered as an
interview to service managers and therapists and will
elicit care-pathway-relevant information, for example, in
relation to service characteristics, team operations, and
the range of interventions available to young people and
their families. CYPRESS will allow the identification of
key programme elements associated with outcome. More
specifically, the use of a common measure will allow com-
parison between MST and MAU along important dimen-
sions of care and potentially provide information on
common aspects of service function associated with out-
come. Such an approach has been used to characterise
other complex interventions in mental health [98]. It will
be of particular value in assessing the key beneficialorganisational components of such a complex inter-
vention as MST when it is deployed in a healthcare
system radically different from that in which it was de-
veloped [99].
Qualitative interviews
To obtain additional information about the experience
of MST and being in an RCT of this treatment, the
semi-structured interview developed by Tighe and col-
leagues in the Brandon Centre trial will be used [100].
This 45-minute interview elicits parents’ and young peo-
ple’s experience of MST or control treatments, and their
views of the costs and the benefits. Semi-structured in-
terviews will be conducted to explore how young people
and their parents or caregivers experienced MST,
whether they think that the young person’s functioning
or carers’ lives have changed following MST (in areas
targeted by the intervention), and whether family rela-
tionships have changed. If the young person or parent
reports changes, the interview will also explore the tim-
ing of those changes and how MST affected the changes.
Interviews will be audio recorded and transcribed ver-
batim. Transcripts will be analysed using framework
analysis, a structured method for analysing themes in
data, developed by Ritchie and Spencer [101], which fa-
cilitates the systematic analysis of large amounts of
qualitative data [100]. The researcher develops a struc-
tured thematic coding framework for the data, which is
then used to systematically record the occurrence of
each of the categories in the entire data set. Charts are
then developed to show the pattern of occurrences of
each theme, and these are used to map and interpret the
data set as a whole.
The intention is for the interview to be administered
to a random 5% of families across all sites by a person
independent of the intervention but not blind to treat-
ment allocation.
Follow-up assessment
Follow-up assessments will be conducted at 6, 12 and 18
months post-randomisation. Table 2 shows a detailed
outline of the planned measures at each follow-up point
throughout the trial.
Statistical analysis plan
All analysis will be according to the intention-to-treat
principle. The characteristics of the treatment groups
will be described at baseline. Preliminary analysis will
investigate the pattern of missing follow-up data.
Primary outcome
The primary analysis will be a logistic regression with
random effects to account for clustering by therapist.
The analysis will include centre, number of past
Table 2 Assessments and schedule of administration in the START trial of multisystemic therapy
Assessment Timeline (months)
Baseline 6 12 18
Eligibility and consent
Eligibility assessed by MST panel x
Consent taken at introductory visit x
Randomisation information provided x
Questionnaires - Parent
Child and Adolescent Service Use Schedule
(excluding last two questions for young person)
x x x x
Demographic Interview for Parents x
General Health Questionnaire-28 x x x x
Conners Comprehensive Behaviour Rating Scale-Parent form x x x x
Inventory of Callous-Unemotional Traits x x x x
Self-Report Delinquency x x x x
Development and Well-Being Assessment x x
Conflict Tactics Scale-Short Form x x x x
Alabama Parenting Questionnaire-Short Form x x x x
Family Adaptability Service Use Schedule-Caregiver Questionnaire x x x x
Loeber Caregiver Questionnaire x x x x
Questionnaires - Young person
Child and Adolescent Service Use Schedule (last two questions) x x x x
Short Mood and Feelings Questionnaire x x x x
Inventory of Callous-Unemotional Traits x x x x
Self-Report Delinquency x x x x
Level of Expressed Emotion x x x x
Wechsler Abbreviated Scale of Intelligence x
Antisocial Beliefs and Attitudes Scale x x x x
Strengths and Difficulties Questionnaire x x x x
Development and Well-Being Assessment x x
Alabama Parenting Questionnaire-Short Form x x x x
Youth Materialism Scale x x x x
EQ-5Da x x x x
Education data
Conners Comprehensive Behaviour Rating Scale-Teacher form x x x x
Attendance/Exclusion rates x x x x
Youth offending data
Offending history x x x x
Interviews
Optional Qualitative interview - parent or carer x
Optional Qualitative interview - young person x
aEQ-5D is a measure of health outcomes (used in the health economic evaluation).
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and other risk indicators as fixed effects. The logistic
regression will be fitted using generalised estimating
equations. A Wald test of the effect of intervention will
be used as the primary analysis. As a secondaryanalysis, tests of interaction will be used to explore
whether the intervention differs according to gender,
age, presence of a criminal record or referral path.
Clustering by therapist will be accounted for by com-
puting robust standard errors [102].
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The antisocial behaviour outcome (time to offence) will
be analysed using a Cox regression. All other secondary
outcomes will be modelled using linear mixed-effects
models, with separate treatment effects for the 6-, 12-
and 18-month outcomes and an unstructured covariance
matrix. The effect of intervention on the 18-month out-
come will be tested using a Wald test. Tests of inter-
action will be performed for all secondary outcomes in
which a nominally significant treatment effect is found.
It is anticipated that the primary outcome will have
very little missing data as these data are obtained inde-
pendently of the participants. For the secondary out-
comes, linear mixed models and Cox regression yield
valid inferences when data are missing at random (that is,
the probability of a particular data point being missing de-
pends only on observed data). It is possible that data may
be missing not at random, so sensitivity analyses will be
conducted to explore the impact of missing data.
There is just one primary outcome, so the primary
analysis will be conducted at a nominal two-sided sig-
nificance level of 0.05. There are several secondary out-
comes, so caveats will be used when interpreting effects
of treatment on secondary outcomes. No formal correc-
tion for multiple testing will be used.
There is no plan to analyse outcomes by site and it is
hoped that TAM-R scores will pick up the variance asso-
ciated with individual therapists.
Discussion
Although a number of high-quality efficacy studies have
demonstrated the success of MST in reducing antisocial
behaviour and out-of-home placements in high-risk
youth, the replicability of the original findings from the
US when MST has been transported internationally has
been mixed, especially when field trials have not in-
volved the developers of the programme. Although the
evidence from the US suggests that MST is a very prom-
ising treatment, the question of whether it will be simi-
larly effective in the UK has not been fully tested.
Substantial attention has been paid in past research to
treatment transportability and fidelity, but variability in
the outcomes of different studies may be due to the
comparison conditions not being adequately comparable
across studies. The provision for antisocial adolescents
in the UK is difficult to compare with that in the US,
and expectations of favourable outcomes relative to
MAU are not based on comparable investigations. The
sole UK study, unlike counterparts in the US, found sta-
tistically significant reductions in non-violent criminality
only after 18 months following randomisation [44]; how-
ever, this was an underpowered investigation with lim-
ited measures of critical outcomes such as self-reported
criminal behaviour and observational or self-reportstudies of mental health and well-being. To assess the ef-
ficacy of MST in the UK context, the START trial will
compare MST with the multi-agency interventions that
are currently provided for these adolescents through the
UK National Health Service by specialist YOTs and by
social services and education services following recom-
mendations by the Social Care Institute for Excellence
and NICE. To ensure that the study achieves the fairest
and least biased assessment of the potential benefits of
MST, the investigators have designed the study with the
support of MST Services but will carry out the RCT inde-
pendently from the developers; however, the developers
have access to the trial sites to ensure that treatments are
delivered at the highest levels of fidelity [97].
The research is being conducted across 10 pilot sites,
each overseen by a team of therapists who have received
specialist training in MST to ensure high-quality delivery
of the intervention. As out-of-home placement (whether
incarceration, hospitalisation, residential schooling or as-
signment to residential local authority care) in the ma-
jority of cases represents an unhelpful outcome for
antisocial adolescents, the investigators have chosen to
use preservation of the family as the main measure of
benefit. As noted above, the rate of out-of-home place-
ment is an important primary outcome, but it is not in
every instance an indication of the failure of the system
to provide adequate support to the young person and
family. Consequently, the authors intend to interpret the
information on family preservation in the context of
combined information collected from measures of family
functioning and home observations to categorise treat-
ment successes and failures regarding out-of-home
placement according to pre-assigned criteria. In doing
so, it will be possible to capture instances where out-
of-home placement is an appropriate outcome and when
it is not; for example, instances when there is no out-
of-home placement but home observation data and self-
report measures suggest that the young person’s situation
remains markedly suboptimal.
MST aims to reduce the level of offending in the target
population, and so offending rates will be used as a key
measure to determine whether the intervention is effect-
ive. Other possible benefits of MST will also be examined,
such as the impact on the young person’s educational pro-
gress, his or her mental health and well-being and that of
the parents. To address the mediators of improvement,
the investigators have taken considerable effort to monitor
the effect of MST on parenting and family function. It is
anticipated that improvement observed in association with
this intervention will be commensurate with the impact
that MST has on variables within the family, and for other
clinically critical outcomes (for example, antisocial peer
group affiliation), to be in line with changes in the pur-
ported mediating processes.
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care will be taken to describe the interventions delivered
to both groups in the study accurately, and the investiga-
tors will attempt to chart the subjective experience of all
stakeholders in the project (that is, service users and pro-
viders and commissioners of services). The data from the
trial will be analysed to determine whether the expected
benefit of MST is achieved and whether it represents an
economically viable option.
The START trial is a pragmatic national RCT that is
of sufficient size to evaluate MST in the UK context to
inform policymakers, commissioners of services, profes-
sionals, service users and their families about the poten-
tial of this treatment in the UK. Given the number and
geographical spread of sites in the MAU condition, the
trial will also provide unprecedented data on the clinical
effectiveness and cost-effectiveness of usual services pro-
vided to young people with serious antisocial behaviour
problems.
The START trial intends to recruit a large sample of 700
young people and their families, who will be evaluated re-
peatedly over a period of 18 months. This will allow their
trajectories of adjustment to be mapped over an extended
period following the intervention. Moreover, the large
sample size, combined with the study design and measure-
ment strategy, will provide for a detailed investigation of
mechanisms related to treatment response. The investiga-
tors are able to build on earlier studies that have found
theoretically consonant mediators [50,67-69]. Few moder-
ators beyond treatment fidelity have been addressed in the
literature on MST. The Norwegian trial of MST [60]
showed that although girls presented a slightly different
problem profile from boys, MST appeared to be robust to
gender. To date, no studies have examined in depth, with
a large sample, which types of young people benefit most
or least from MST. For example, there are outstanding is-
sues regarding whether MST is equally effective across the
diverse range of ethnicities in the UK, as well as with the
emotional comorbidities associated with antisocial behav-
iour such as anxiety and depression (the latter particularly
in females). Ethnic match between therapist and youth has
been observed to be associated with short-term treatment
effectiveness [103] but not long-term criminal outcomes
[104]. One small-scale study contrasted the outcomes
of MST in youths presenting with pure externalising
problems versus those with mixed internalising and
externalising problems [105]. Youths with mixed presenta-
tions benefited somewhat less; in addition, the extent of
their change in clinician-rated externalising behaviour was
associated with maternal depression. In post hoc analyses,
with appropriate caveats, this study will permit starting
the process of identifying the specific subgroups of youth
who uniquely benefit from MST as opposed to MAU. This
will have obvious practical benefits to services which haveto treat a large, heterogeneous group of youth showing
antisocial behaviour.
The investigators will undertake several initiatives that
are essential to understanding the impact and cost-
effectiveness of MST in the UK. Building on an initial
qualitative study of MST in the Brandon Centre trial [44],
young people and their carers will be interviewed to elicit
their views on receiving this intensive, ecologically valid
intervention and, specifically, to learn what factors they
identify as having facilitated or inhibited treatment change.
The qualitative interviews provide an opportunity to collect
outcome data that can then be triangulated with the rele-
vant and comparable quantitative outcome measures. This
entails a process of interpretation whereby quantitative
findings regarding the primary and secondary outcomes
will be complemented with participants’ descriptions of
processes that they believe contributed to improvements
or the absence of desired change. As an illustrative ex-
ample, qualitative findings from the Brandon Centre trial
showed that parents identified their son’s continued associ-
ation with deviant peers as an important factor when they
continued to engage in criminal behaviour. The investiga-
tors will also undertake to carefully define and track what
services are given in the MAU condition, and to study the
organisational or service factors that may contribute to
outcome. Finally, a comprehensive cost-effectiveness evalu-
ation will be undertaken to look at both costs offset (for ex-
ample, in juvenile justice) and costs saved (for example, by
youths remaining in mainstream education) in relation to
having received MST or MAU services.
Trial status
Ongoing. Sites were launched in five phases, once they
were well embedded in their local authority and services
were familiar with the referral process and eligibility cri-
teria. Recruitment began in February 2010 and recruit-
ment is expected to be complete 18 months after the
launch of the last site. Outcome data will be available 18
months post-randomisation of the last participant.
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